Home › Cardiovascular Disease › NCT07106879
Non-interventional Pre-screening Protocol Aims to Evaluate Participants for Potential Trial Eligibility in Future Clinical Trials/Studies Focusing on Metabolic and Psychiatric Health.
Pre-screening Survey for Metabolic, Cardiovascular, Obesity, Mental Health, and Endocrine Trial Eligibility (DOVE-MET-COME-100)
Who can join
Ages 18 and older · All sexes · Healthy volunteers welcome
Full eligibility criteria
Inclusion Criteria: * Any participant of age 18 years and over * Who are willing to provide informed consent and participate in the pre-screening study and comply with study procedures. Exclusion Criteria: * Pregnant or breastfeeding individuals * Individuals having severe cognitive impairment or inability to provide informed consent * Individuals having acute psychiatric emergencies requiring immediate intervention/hospitalization * Individuals who are currently participating in another research study that conflicts with pre-screening data collection * Individuals having known history of drug/alcohol misuse * Individuals having medical conditions that, in the investigator's opinion, could compromise the integrity of the screening process or pose significant risks to the participant's health.
About the study
DOVE-MET-COME-100 is a single site prescreening survey study designed to identify adults who may be eligible for future industry-sponsored clinical trials. A physician will oversee the informed consent process, after which participants will be surveyed on demographics, medical history, current health conditions and symptoms. The study team may also collect basic health information, including vital signs, urine drug tests, blood samples and pregnancy tests (if applicable). A physician will review each participant's medical history in a one-on-one interview to assess potential fit for upcoming trials. If needed, the doctor may contact the participant's current doctors or pharmacies to gather more information for eligibility review.
What is being tested
- Blood Work (other)
Sponsor: Clindove Research LLC · Participants: 7,000 · Started: Jul 30, 2025
Contact the study team
- Nelly Cohen, MD · Phone: 516-518-3239
Official record on ClinicalTrials.gov — NCT07106879
Locations in the U.S.
| New York | Clindove Research LLC, Brooklyn |
Conditions
From ClinicalTrials.gov, data retrieved Sep 30, 2026. Each study sets its own eligibility; the study team decides who can join.